Clearview Recovery Inc Prairie City
-
Services:
- Prescribes buprenorphine
- Prescribes naltrexone
- Accepts clients using MAT but prescribed elsewhere
- Relapse prevention with naltrexone
- Mental health services
- Social skills development
- Domestic violence services, including family or partner
- Residential beds for clients’ children
- Integrated primary care services
- Case management service
- Other contracted prescribing entity
- Trauma-related counseling
- Relapse prevention
- Motivational interviewing
- Brief intervention
- Matrix Model
- Cognitive behavioral therapy
- 12-step facilitation
- Telemedicine/telehealth therapy
- Substance use disorder counseling
- Contingency management/motivational incentives
- Anger management
- Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)
- Clients who have experienced trauma
- Members of military families
- Adult women
- Seniors or older adults
- Clients who have experienced sexual abuse
- Criminal justice (other than DUI/DWI)/Forensic clients
- Veterans
- Clients who have experienced intimate partner violence, domestic violence
- Pregnant/postpartum women
- Young adults
- Clients with HIV or AIDS
- Clients with co-occurring mental and substance use disorders
- Discharge Planning
- Aftercare/continuing care
- Naloxone and overdose education
- Female
- Smoking permitted in designated area
- Screening for tobacco use
- Comprehensive substance use assessment
- Complete medical history/physical exam
- Screening for substance use
- Screening for mental disorders
- Private non-profit organization
- This facility administers/prescribes medication for alcohol use disorder
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- Medicaid
- Cash or self-payment
- Drug or alcohol urine screening
- Breathalyzer or blood alcohol testing
- Substance use treatment
- Transitional housing, halfway house, or sober home
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Acamprosate (Campral®)
- Naltrexone (extended-release, injectable)
- Buprenorphine without naloxone
- Naltrexone (oral)
- Clonidine
- Disulfiram
- Medications for Hepatitis C treatment
- Medications for HIV treatment
- Non-nicotine smoking/tobacco cessation
- Medication for mental disorders
- Nicotine replacement
- Buprenorphine (extended-release, injectable)
- Buprenorphine with naloxone
- Treatment for other addiction disorder
- Housing services
- Mentoring/peer support
- Self-help groups
- Assistance with obtaining social services
- Vaping permitted in designated area
- Other contracted prescribing entity
- Long-term residential
- Intensive outpatient treatment
- Regular outpatient treatment
- Outpatient methadone/buprenorphine or naltrexone treatment
- Short-term residential
- Residential/24-hour residential
- Outpatient day treatment or partial hospitalization
- Outpatient
- Hepatitis education, counseling, or support
- Smoking/vaping/tobacco cessation counseling
- Substance use disorder education
- Group counseling
- Health education services other than HIV/AIDS or hepatitis
- HIV or AIDS education, counseling, or support
- Family counseling
- Individual counseling
- State Substance use treatment agency
- State department of health
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
Type of Opioid Treatment
Ancillary Services
External Source of Medications Used for Alcohol Use Disorder Treatment
Treatment Approaches
Special Programs/Groups Offered
Transitional Services
Gender Accepted
Facility Smoking Policy
Assessment/Pre-treatment
Facility Operation (e.g., Private, Public)
Type of Alcohol Use Disorder Treatment
Payment/Insurance/Funding Accepted
Testing
Type of Care
Pharmacotherapies
Other Services
Recovery Support Services
Facility Vaping Policy
External Opioid Medications Source
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Education and Counseling Services
License/Certification/Accreditation
Opioid Medications used in Treatment